The significance of bilateral cardiomyopathy in VIP−/− mice is that this links the VIP gene to critical whole heart myosin gene overexpression, tied to abnormal function in its absence, and supports the concept of VIP therapy for cardiac disease. This evidence concerns the gene MYH14 and cardiomyopathy.